The morning opened up on a high note for this dually-listed company as it announced U.S. Food and Drug Administration (FDA) approval of its Metronidazole Oral Suspension 500mg/5mL ( ATI-1501 )....

To read the full story on AllPennyStocks.com, click here.

Appili Therapeutics (TSX:APLI)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024 Click aqui para mais gráficos Appili Therapeutics.
Appili Therapeutics (TSX:APLI)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024 Click aqui para mais gráficos Appili Therapeutics.